XAIR
Beyond Air, Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Sell
-50/100
Last price
2.55
▼ 0.29 (10.21%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
2.84
Day high
2.80
Day low
2.55
Volume
36.28K
Market cap
$2.51M
P/E (TTM)
—
52W range
2.38 – 55.60
Trailing performance
Returnvs SPY
1W
-9.89%
-11.8%
1M
-27.76%
-28.9%
3M
-71.09%
-75.6%
6M
-82.04%
-100.2%
YTD
-82.44%
-96.7%
1Y
-94.75%
-111.2%
3Y
-99.72%
-182.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on XAIR open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
214.28K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jul 21, 25 | LISI STEVEN A Chief Executive Officer |
BUY | 6.00K | $19.49K | Direct |
| Mar 14, 25 | CAREY ROBERT F. Director |
BUY | 1.00M | $250.05K | Direct |
| Feb 19, 25 | GAUL MICHAEL A Chief Operating Officer |
BUY | 6.00K | $2.29K | Direct |
| Sep 26, 24 | CAREY ROBERT F. Director |
BUY | 1.48M | $744.66K | Indirect |
| Sep 26, 24 | LISI STEVEN A Chief Executive Officer |
BUY | 1.48M | $744.66K | Direct |
| Aug 15, 24 | LISI STEVEN A Chief Executive Officer |
BUY | 50.00K | $18.34K | Direct |
| Aug 14, 24 | CAREY ROBERT F. Director |
BUY | 100.00K | $39.68K | Direct |
| Aug 14, 24 | LUCERA ERICK J. Director |
BUY | 39.27K | $15.56K | Direct |
| Aug 14, 24 | LISI STEVEN A Chief Executive Officer |
BUY | 100.00K | $38.64K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CAREY ROBERT F. |
Director | 5.55M | Purchase |
GAUL MICHAEL A |
Chief Operating Officer | 94.15K | Purchase |
LISI STEVEN A |
Chief Executive Officer | 3.33M | Purchase |
LUCERA ERICK J. |
Director | 43.61K | Purchase |
Fundamentals
Market cap$2.51M
Enterprise value$17.07M
Revenue (TTM)$7.69M
Gross profit$321.00K
EBITDA$-24.80M
Net income$-33.49M
EPS (TTM)$-64.40
Free cash flow$-14.07M
Total cash$9.81M
Total debt$23.60M
Book value / share$2.69
Shares outstanding984.41K
Float764.20K
Short % of float6.11%
Dividend yield0.00%
Beta (5Y)0.21
Valuation & profitability ratios
Trailing P/E—
Forward P/E-1.54
PEG ratio—
Price / sales—
Price / book0.95
EV / revenue2.22
EV / EBITDA-0.69
Gross margin4.18%
Operating margin-373.98%
Profit margin0.00%
Return on equity-519.51%
Return on assets-57.45%
Debt / equity831.21
Current ratio3.31
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $7.68M | $3.71M | $1.16M | $0 | +107.3% |
| Operating revenue | $7.68M | $3.71M | $1.16M | $0 | +107.3% |
| Cost of revenue | $7.43M | $5.37M | $2.47M | $555.00K | +38.4% |
| Gross profit | $252.00K | -$1.66M | -$1.31M | -$555.00K | +115.2% |
| Research & development | $10.24M | $16.86M | $24.36M | $16.81M | -39.2% |
| Selling, general & admin | $19.05M | $26.02M | $37.34M | $34.69M | -26.8% |
| Total operating expense | $29.30M | $42.87M | $61.70M | $51.50M | -31.7% |
| Operating income | -$29.04M | -$44.54M | -$63.01M | -$52.06M | +34.8% |
| Net interest income | -$3.52M | -$3.02M | -$2.91M | -$30.00K | -16.4% |
| Pre-tax income | -$34.33M | -$48.48M | -$64.30M | -$59.40M | +29.2% |
| Tax provision | $0 | $0 | $0 | $0 | — |
| Net income | -$33.25M | -$46.63M | -$60.24M | -$55.82M | +28.7% |
| Net income to common | -$33.25M | -$46.63M | -$60.24M | -$55.82M | +28.7% |
| Basic EPS | -80.20 | -276.00 | -728.00 | -744.00 | +70.9% |
| Diluted EPS | -80.20 | -276.00 | -728.00 | -744.00 | +70.9% |
| EBIT | -$30.82M | -$45.46M | -$61.38M | -$59.37M | +32.2% |
| EBITDA | -$27.17M | -$41.89M | -$59.03M | -$58.20M | +35.1% |
| Basic shares | 415.05K | 169.27K | 82.90K | 74.93K | +145.2% |
| Diluted shares | 415.05K | 169.27K | 82.90K | 74.93K | +145.2% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $6.74M | $4.67M | $11.38M | $29.16M | +44.5% |
| Cash & short-term investments | $11.64M | $6.92M | $34.47M | $45.88M | +68.3% |
| Accounts receivable | $1.09M | $710.00K | $319.00K | $0 | +53.0% |
| Inventory | $1.41M | $2.42M | $2.13M | $1.13M | -41.8% |
| Total current assets | $24.77M | $16.02M | $43.94M | $59.41M | +54.6% |
| Property, plant & equipment | $9.44M | $12.72M | $11.48M | $7.50M | -25.8% |
| Goodwill & intangibles | $1.02M | $1.22M | $1.43M | $1.63M | -16.7% |
| Total assets | $35.38M | $30.06M | $56.96M | $68.75M | +17.7% |
| Total current liabilities | $6.51M | $5.00M | $11.57M | $19.78M | +30.2% |
| Current debt | $401.00K | $609.00K | $800.00K | $775.00K | -34.2% |
| Long-term debt | $21.64M | $9.20M | $14.72M | $120.00K | +135.3% |
| Total debt | $23.38M | $11.69M | $17.84M | $3.59M | +100.1% |
| Total liabilities | $29.18M | $15.72M | $29.77M | $26.72M | +85.6% |
| Retained earnings | -$319.57M | -$286.32M | -$239.70M | -$179.46M | -11.6% |
| Shareholder equity | $6.13M | $13.58M | $25.05M | $37.91M | -54.9% |
| Working capital | $18.26M | $11.02M | $32.37M | $39.63M | +65.7% |
| Net tangible assets | $5.11M | $12.36M | $23.62M | $36.28M | -58.7% |
| Shares issued | 589.63K | 206.43K | 114.75K | 76.85K | +185.6% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | -$34.33M | -$48.48M | -$64.30M | -$59.40M | +29.2% |
| Depreciation & amortisation | $3.65M | $3.57M | $2.35M | $1.17M | +2.2% |
| Stock-based compensation | $5.28M | $9.15M | $21.34M | $19.56M | -42.2% |
| Change in working capital | $2.35M | -$6.15M | -$16.04M | $5.39M | +138.1% |
| Operating cash flow | -$18.14M | -$38.22M | -$56.01M | -$33.01M | +52.5% |
| Capital expenditure | -$1.02M | -$5.88M | -$5.75M | -$3.88M | +82.6% |
| Investing cash flow | -$3.67M | $14.90M | -$12.23M | -$20.59M | -124.6% |
| Financing cash flow | $29.09M | $16.65M | $43.17M | $2.70M | +74.8% |
| Free cash flow | -$19.17M | -$44.10M | -$61.76M | -$36.89M | +56.5% |
| End cash position | $12.36M | $4.90M | $11.61M | $36.77M | +152.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $1.77M | $1.91M | $2.19M | $1.82M | $1.76M | -7.3% |
| Operating revenue | $1.77M | $1.91M | $2.19M | $1.82M | $1.76M | -7.3% |
| Cost of revenue | $1.54M | $1.81M | $1.89M | $2.12M | $1.60M | -14.9% |
| Gross profit | $225.00K | $94.00K | $300.00K | -$298.00K | $156.00K | +139.4% |
| Research & development | $1.96M | $2.28M | $2.43M | $2.45M | $3.09M | -13.9% |
| Selling, general & admin | $4.88M | $4.99M | $4.47M | $4.91M | $4.69M | -2.2% |
| Total operating expense | $6.84M | $7.26M | $6.90M | $7.36M | $7.77M | -5.9% |
| Operating income | -$6.61M | -$7.17M | -$6.60M | -$7.66M | -$7.62M | +7.8% |
| Net interest income | -$1.49M | -$1.24M | -$1.09M | -$639.00K | -$548.00K | -20.3% |
| Pre-tax income | -$8.15M | -$10.37M | -$7.63M | -$8.26M | -$8.08M | +21.4% |
| Tax provision | $0 | $0 | $0 | $0 | $0 | — |
| Net income | -$7.93M | -$10.28M | -$7.34M | -$7.94M | -$7.69M | +22.8% |
| Net income to common | -$7.93M | -$10.28M | -$7.34M | -$7.94M | -$7.69M | +22.8% |
| Basic EPS | -220.00 | -15.40 | -17.00 | -25.00 | -613.40 | -1,328.6% |
| Diluted EPS | -220.00 | -15.40 | -17.00 | -25.00 | -613.40 | -1,328.6% |
| EBIT | -$6.66M | -$9.13M | -$6.54M | -$7.62M | -$7.53M | +27.0% |
| EBITDA | -$5.74M | -$8.21M | -$5.65M | -$6.70M | -$6.60M | +30.1% |
| Basic shares | 36.07K | 664.40K | 430.84K | 317.83K | 12.54K | -94.6% |
| Diluted shares | 36.07K | 664.40K | 430.84K | 317.83K | 12.54K | -94.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $5.51M | $6.74M | $6.64M | $9.70M | $4.98M | — | -18.3% |
| Cash & short-term investments | $9.81M | $11.64M | $11.66M | $10.70M | $6.46M | — | -15.7% |
| Accounts receivable | $1.14M | $1.09M | $1.15M | $892.00K | $804.00K | — | +5.0% |
| Inventory | $1.29M | $1.41M | $1.76M | $2.23M | $2.43M | — | -8.1% |
| Total current assets | $22.85M | $24.77M | $25.56M | $18.59M | $14.99M | — | -7.7% |
| Property, plant & equipment | $8.98M | $9.44M | $9.97M | $10.95M | $11.84M | — | -4.9% |
| Goodwill & intangibles | $966.00K | $1.02M | $1.07M | $1.12M | $1.17M | — | -5.1% |
| Total assets | $32.89M | $35.38M | $36.77M | $30.96M | $28.11M | — | -7.0% |
| Total current liabilities | $6.91M | $6.51M | $4.99M | $4.38M | $4.63M | — | +6.1% |
| Current debt | $231.00K | $401.00K | — | — | $233.00K | $609.00K | -42.4% |
| Long-term debt | $22.17M | $21.64M | $21.97M | $12.17M | $11.64M | — | +2.4% |
| Total debt | $23.60M | $23.38M | $23.59M | $13.88M | $13.71M | — | +0.9% |
| Total liabilities | $30.05M | $29.18M | $28.49M | $17.87M | $17.71M | — | +3.0% |
| Retained earnings | -$327.51M | -$319.57M | -$309.29M | -$301.95M | -$294.01M | — | -2.5% |
| Shareholder equity | $2.00M | $6.13M | $8.11M | $12.73M | $9.93M | — | -67.4% |
| Working capital | $15.94M | $18.26M | $20.57M | $14.20M | $10.36M | — | -12.7% |
| Net tangible assets | $1.03M | $5.11M | $7.04M | $11.61M | $8.76M | — | -79.8% |
| Shares issued | 743.42K | 589.63K | 420.22K | 400.47K | 234.66K | — | +26.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$8.15M | -$10.37M | -$7.63M | -$8.26M | -$8.08M | +21.4% |
| Depreciation & amortisation | $920.00K | $915.00K | $892.00K | $916.00K | $926.00K | +0.5% |
| Stock-based compensation | $1.04M | $427.00K | $1.50M | $1.77M | $1.58M | +142.6% |
| Change in working capital | $15.00K | $1.03M | $261.00K | $410.00K | $645.00K | -98.5% |
| Operating cash flow | -$4.95M | -$4.95M | -$4.22M | -$4.45M | -$4.53M | 0.0% |
| Capital expenditure | -$208.00K | -$547.00K | -$34.00K | -$246.00K | -$198.00K | +62.0% |
| Investing cash flow | $461.00K | -$447.00K | -$4.04M | $240.00K | $576.00K | +203.1% |
| Financing cash flow | $3.06M | $4.90M | $11.21M | $8.92M | $4.07M | -37.6% |
| Free cash flow | -$5.15M | -$5.49M | -$4.25M | -$4.70M | -$4.72M | +6.2% |
| End cash position | $10.91M | $12.36M | $12.83M | $9.86M | $5.14M | -11.7% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2025 | -26.40 | -30.60 | -15.9% |
| Mar 2025 | -48.80 | -36.00 | +26.2% |
| Dec 2024 | -64.00 | -60.00 | +6.3% |
| Sep 2024 | -113.60 | -112.00 | +1.4% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | -3.32 | 2 | $2.01M | +152.3% |
| Current year | -26.70 | 2 | $8.00M | +116.0% |
| Next year | -8.04 | 2 | $16.72M | +108.8% |
Analyst targets & ownership
Mean target$20.00
High target$30.00
Low target$10.00
Implied upside684.31%
Analyst count2
ConsensusNONE
Strong buy / Buy1 / 1
Hold0
Sell / Strong sell0 / 0
Held by insiders22.38%
Held by institutions7.00%
Institutions holding30
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
2.83
-10.05% from price
SMA 20
2.98
-14.50% from price
SMA 50
4.29
-40.53% from price
SMA 100
6.14
-58.50% from price
SMA 200
12.00
-78.75% from price
EMA 12
2.89
-11.84% from price
EMA 26
3.34
-23.66% from price
EMA 50
4.28
-40.46% from price
RSI (14)
32.0
Neutral
MACD (12,26,9)
-0.45
Hist 0.06
ATR (14)
0.25
9.65% of price
Realised vol 30D
110.9%
Annualised
Bollinger upper
3.37
20, 2σ
Bollinger lower
2.59
20, 2σ
50 / 200 cross
Death
4.29 vs 12.00
Trend bias
Below 200
-78.75%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.58
Less volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
110.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-95.3%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.25
9.65% of price
Beta (reported)
0.21
5Y monthly, from filing
Short interest
Shares short
59.32K
Prior 27.57K
Change vs prior
+115.1%
Shorts adding
% of float
6.11%
Normal
% of shares out
6.03%
Against total outstanding
Days to cover
0.1
Liquid
Float
764.20K
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 1, 26 | Lake Street | INITIATED | — | Buy |
| Mar 27, 26 | D. Boral Capital | MAINTAINED | Buy | Buy |
| Mar 18, 26 | D. Boral Capital | MAINTAINED | Buy | Buy |
| Mar 10, 26 | D. Boral Capital | MAINTAINED | Buy | Buy |
| Jan 21, 26 | D. Boral Capital | MAINTAINED | Buy | Buy |
| Nov 11, 25 | D. Boral Capital | MAINTAINED | Buy | Buy |
| Aug 21, 25 | D. Boral Capital | MAINTAINED | Buy | Buy |
| Aug 13, 25 | D. Boral Capital | MAINTAINED | Buy | Buy |
| Jul 17, 25 | D. Boral Capital | INITIATED | — | Buy |
| Aug 7, 24 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Jun 25, 24 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Jun 25, 24 | BTIG | DOWNGRADE | Buy | Neutral |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay dateJan 10, 2017
Last split1:20
Split dateJul 13, 2026
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-24
Corporate Changes & Voting Matters
8-K · 2026-08-18
Offering Registrations
S-3 · 2026-08-17
Periodic Financial Reports
10-Q · 2026-08-13
Corporate Changes & Voting Matters
8-K · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-07-31
Corporate Changes & Voting Matters
8-K · 2026-07-09
Periodic Financial Reports
10-K · 2026-06-26
Headlines
Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference
GlobeNewswire · 35d ago
Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
GlobeNewswire · 37d ago
Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments
GlobeNewswire · 43d ago
Beyond Air (XAIR) Q1 2027 Earnings Call Transcript
Motley Fool · 54d ago
Beyond Air Inc (XAIR) (Q1 2027) Earnings Call Highlights: Strategic Financing and Pipeline ...
GuruFocus.com · 54d ago
Beyond Air, Inc. Q1 2027 Earnings Call Summary
Moby · 55d ago
Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update
GlobeNewswire · 55d ago
Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026
GlobeNewswire · 64d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.